Literature DB >> 21616049

Influenza A(H1N1)2009 antibody seroprevalence in Scotland following the 2010/11 influenza season.

W E Adamson1, E C McGregor, K Kavanagh, J McMenamin, S McDonagh, P J Molyneaux, K E Templeton, W F Carman.   

Abstract

Following the 2010/11 influenza season, we determined the age- and location-specific seroprevalence of antibodies against the influenza A(H1N1)2009 virus in Scotland. Samples were analysed by microneutralisation assay. Age/seropositivity profiles varied significantly between cities. The increases in seroprevalence relative to the previous influenza season (2009/10) were similar across age groups and geographic locations. However, the increased seropositivity in older adults appeared to be driven by exposure to vaccination, indicating significantly lower levels of infection than in younger age groups.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21616049

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  4 in total

1.  H1N1v at a seroepidemiological glance: is the nightmare over?

Authors:  C Reinheimer; H W Doerr; I Friedrichs; M Stürmer; R Allwinn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-09       Impact factor: 3.267

2.  Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA.

Authors:  Ted M Ross; Lu Hairong; Bing Shao Chia; Elaise Hill; Heather Weirback; Shanta Zimmer
Journal:  PLoS Curr       Date:  2011-10-25

3.  Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.

Authors:  Andreas Mörner; Andreas Bråve; Anna-Maria Kling; Sharon Kühlmann-Berenzon; Katarina Krook; Mona Hedenskog; Irene Silhammar; Margaretha Ljungman; Ake Ortqvist; Sören Andersson; Maria Brytting; Rigmor Thorstensson; Annika Linde
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

4.  Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population.

Authors:  Nathanael Lapidus; Xavier de Lamballerie; Nicolas Salez; Michel Setbon; Rosemary M Delabre; Pascal Ferrari; Nanikaly Moyen; Marie-Lise Gougeon; Frédéric Vely; Marianne Leruez-Ville; Laurent Andreoletti; Simon Cauchemez; Pierre-Yves Boëlle; Eric Vivier; Laurent Abel; Michaël Schwarzinger; Michèle Legeas; Pierre Le Cann; Antoine Flahault; Fabrice Carrat
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.